Clinical trial
Phase III Nonoxynol-9 and HIV Infection
NCT00000926 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Nonoxynol-9 and HIV Infection
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- February 28, 2001
- Enrollment
- 4,400
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.